University of Texas at Arlington research projects contributed $59 million to the national economy in 2024—an increase of 39% from 2023, according to a new report from the Institute for Research on Innovation and Science (IRIS). UTA has invested heavily in research infrastructure, purchasing cutting-edge scientific equipment and technology, such as North Texas’ most advanced gene sequencer and a super-sensitive magnetic resonance imaging machine for the Clinical Imaging Research Center. The funds also support collaboration with other research organizations. 

AI is reshaping workplaces, particularly in retail. Researchers explored how AI service quality impacts retail employees’ innovation, job fit, and satisfaction. Findings show when employees perceive AI as reliable and empathetic, they are more likely to engage in innovative behavior. AI’s adaptability also plays a crucial role in enhancing service quality. While reliability strongly supports innovation, transparency and responsiveness had less influence than expected. Empathy in AI systems was found to have a significant positive effect on employee innovation, creating a more engaging work environment. The study underscores AI’s potential to drive service innovation in retail.

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicineat Texas Tech University Health Sciences Center (TTUHSC) and director of the University Medical Center (UMC) Cancer Center, shared groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in Renal Cell Carcinoma) study. The findings underscore the critical role of tumor size reduction in improving survival outcomes for patients with advanced renal cell carcinoma (aRCC).